Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Research News
back to News Search
     
New Genetic Variations Link Schizophrenia and Bipolar Disorder

27 September 2006. Schizophrenia and bipolar disorder are debilitating psychiatric diseases with considerable overlap. They share multiple symptoms, and there is evidence that both occur in the same extended families more often than predicted by chance. This has led to the theory that variations within certain genes can increase susceptibility to both diseases (see SRF live discussion). Though the search for such susceptibility variations can be extremely complex—carriers are most often completely normal, for example, making it difficult to trace who does and who does not have a disease variant—researchers in Europe and the U.S. have just added two new genetic loci to the list of those linking schizophrenia and bipolar disorder.

In an article published online September 19 in Human Molecular Genetics, a collaboration led by Hamid Mostafavi Abdolmaleky and Sam Thiagalingam at Boston University, and Ming Tsuang at Harvard University, and comprising researchers from those and several other institutions, reports that reduced methylation of a gene coding for membrane-bound catechol-O-methyltransferase (MB-COMT), an enzyme that plays a crucial role in degrading the neurotransmitter dopamine and other catecholamines, is a major risk factor for the two diseases. In addition, a paper published online September 12 in Molecular Psychiatry, by Giovanni Vazza and colleagues at the University of Padova in Italy, identifies a shared susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26. Together, the papers not only strengthen the connection between the two disorders, but the COMT data also help explain the molecular basis for both, as well as shedding light on how the environment may influence a person’s chance of developing schizophrenia or bipolar disorder.

Too much degradation?
The identification of COMT as a susceptibility locus is not unexpected. Two variants of the COMT gene, differing by a single letter of genetic code, were previously identified, and one of them, producing a valine instead of a methionine at amino acid position 158 of the protein, was linked to schizophrenia (see SRF related news story). But in finding that the COMT gene in schizophrenia and bipolar patients is poorly methylated, Abdolmaleky and colleagues add a new twist. While this chemical modification has no effect on the genetic code itself, it can dramatically change gene activity by preventing DNA from interacting with the machinery that converts the genetic code into protein. In keeping with this, the researchers found that in postmortem samples of dorsolateral prefrontal cortex taken from 35 schizophrenia and 35 bipolar patients, the promoter region of MB-COMT—the very switch that turns on and off the gene—is the one that is poorly methylated. (Note: separate promoters generate membrane-bound and soluble COMT from the same gene.)

In theory, hypomethylation of the MB-COMT gene promoter could lead to increased gene activity, elevated COMT enzyme in the brain, and increased degradation of dopamine, perhaps explaining the loss of this neurotransmitter in the brains of schizophrenia patients (see Akil et al., 1999 and SRF related news story). In support of this idea, Abdolmaleky and colleagues used a cell-based assay to confirm earlier data that hypomethylation of COMT does indeed lead to increased gene expression, and they also compared the amount of COMT mRNA in brain extracts from schizophrenia patients and age-matched controls. Quantitative DNA amplification following reverse transcription revealed that COMT mRNA levels in patients were significantly higher in patients than controls (almost threefold in samples from the Harvard Brain Tissue Resource Center, though not as great a difference in samples from the Stanley Medical Research Institute). The researchers also found an inverse relationship between the levels of COMT and dopamine receptor DRD1 expression that translates into an overall hypoexpression of DRD1 in patients. Taken together, the data suggest that COMT and DRD1 levels may conspire to deprive patients of sufficient dopaminergic transmission.

Like all susceptibility variations, the effect of the MB-COMT hypomethylation is not all-or-none. The researchers found that the gene promoter was hypomethylated in 40 percent of controls compared to 74 and 71 percent of schizophrenia and bipolar patients, respectively. Interestingly, when Abdolmaleky and colleagues separately measured methylation status in samples from the left and right hemispheres of the brain, they found that the patient/control differences were more pronounced in the left side of the brain. In controls, hypomethylation of the promoter only occurred 20 percent of the time in the left side of the brain as opposed to 59 percent in the right side. This seems to suggest that the left side may be more susceptible to changes in methylation status, which would fit with the important role of the left hemisphere in schizophrenia. The language center of the brain is located in the left hemisphere in most people, and many of the symptoms of the disease have been linked to loss of brain laterality and to language difficulties. The loss of brain laterality of MB-COMT promoter methylation in the patients is consistent with other evidence indicating that brain laterality is lost in schizophrenia and bipolar patients (e.g., Crow, 1990).

But the methylation link speaks to a much broader theme, namely the cross-talk between the environment and genetic regulation. Environmental stimuli can cause profound changes in gene expression and behavior due to methylation or demethylation of specific genes (see SRF related news story). This paper hints at a disease/environment nexus that impacts COMT methylation. In fact, the researchers addressed this issue, correlating alcohol use with MB-COMT promoter modification in the patients. They found that methylation was more likely in heavy and moderate alcohol consumers. However, this trend could not be tracked in controls, as heavy and moderate alcohol abuse was not frequent in the control subjects.

The authors note that the sample size in this study was fairly small. “Our analyses reported here provide a clear trend that needs to be further validated in a larger population in future studies,” they write. This includes their finding that the valine allele at position 158 of the COMT enzyme seems to be enriched in samples that also have the promoter hypomethylation. The valine variant is a more active enzyme than that with methionine at the same position, suggesting that patients may be doubly impacted, first by overproduction of the protein, and second, by the fact that the protein is more active than normal.

In the second paper, Vazza and colleagues report that an as-yet uncharacterized locus on a small segment of chromosome 15 links to schizophrenia, bipolar disorder, and schizoaffective disorder in a small group of families in northeastern Italy. The locus lies very close to the ST8SIA2 gene, coding for sialyltransferase 8B, which was recently linked to schizophrenia in a Japanese population (see Arai et al., 2005).

Vazza and colleagues performed genome-wide analysis on 57 individuals in 16 families originating from Chioggia, a “culturally closed” community on an island in the Venetian lagoon. Seven families had only schizophrenia patients, two families had only bipolar patients, and the other seven families had members with two or more of the three disorders. The researchers identified four potential susceptibility loci on chromosomes 1p36, 1q43, 4p14, and 15q26. Only the latter stood up to rigorous statistical analysis, giving a logarithm of odds score greater than 3.0.

Though it lies close to the ST8SIA2 gene, this new 15q26 locus lies about 5Mb away. Furthermore, when Vazza and colleagues analyzed ST8SIA2 single nucleotide polymorphisms (SNPs) that were linked to schizophrenia in the Japanese study, they found no difference between SNP frequencies in the Chioggia population and control populations from other Italian regions. The data indicate that there may be another gene on chromosome 15q that confers susceptibility to schizophrenia and bipolar disorder.—Tom Fagan.

References:
Abdolmaleky HM, Cheng K-H, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT, Thiagalingam S. Hypomethylation of MB-COMT Promoter is a Major Risk Factor for Schizophrenia and Bipolar Disorder. Hum. Mol. Genet. 19 September, 2006. Advanced online publication. Abstract

Vazza G, Bertolin C, Scudellaro E, Vettori A, Boaretto F, Rampinelli S, De Sanctis G, Perini G, Peruzzi P, Mostacciuolo ML. Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26. Mol Psychiatry. 2006 Sep 12; [Epub ahead of print] Abstract

 
Comments on News and Primary Papers
Comment by:  Mary Reid
Submitted 28 September 2006 Posted 29 September 2006

It's of interest that Vazza and colleagues suggest that 15q26 is a new susceptibility locus for schizophrenia and bipolar disorder. I have suggested that reduced function of the anti-inflammatory SEPS1 (selenoprotein S) at 15q26.3 may reproduce the neuropathology seen in schizophrenia.

View all comments by Mary Reid


Comment by:  Patricia Estani
Submitted 5 October 2006 Posted 6 October 2006
  I recommend the Primary Papers
Comments on Related News
Related News: Chromosome 22 Link to Schizophrenia Strengthened

Comment by:  Anthony Grace, SRF Advisor (Disclosure)
Submitted 5 November 2005 Posted 5 November 2005

The fact that the PRODH alteration studied in Gogos et al. leads to alterations in glutamate release, and this corresponds to deficits in associative learning and response to psychotomimetics, provides a nice parallel to the human condition. The Reiss paper examines humans with the 22q11.2 deletion, and shows that the COMT low-activity allele of this deletion syndrome correlates with cognitive decline, PFC volume, and development of psychotic symptoms. This is a nice addition to the Weinberger and Bilder papers about how COMT can lead to psychosis vulnerability.

View all comments by Anthony Grace


Related News: Chromosome 22 Link to Schizophrenia Strengthened

Comment by:  Caterina Merendino
Submitted 5 November 2005 Posted 5 November 2005
  I recommend the Primary Papers

Related News: Chromosome 22 Link to Schizophrenia Strengthened

Comment by:  Leboyer Marion
Submitted 6 November 2005 Posted 6 November 2005
  I recommend the Primary Papers

Related News: Chromosome 22 Link to Schizophrenia Strengthened

Comment by:  Anne Bassett
Submitted 7 November 2005 Posted 7 November 2005
  I recommend the Primary Papers

I echo Jeff Lieberman's comment regarding previous reports of a weak association between the Val COMT functional allele and schizophrenia. Notably, the most recent meta-analysis (Munafo et al., 2005) shows no significant association. Even in 22q11.2 deletion syndrome (22qDS), our group (unpublished) and Murphy et al. (1999) have reported that there is no association between COMT genotype and schizophrenia, and Bearden et al. reported that Val-hemizygous patients performed significantly worse than Met-hemizygous patients on executive cognition ( 2004) and childhood behavioral problems (2005). Though important as an initial prospective study, there is a risk in the Gothelf et al. small sample size and multiple testing for type 1 errors. Certainly, there is little...  Read more


View all comments by Anne Bassett

Related News: SfN 2005: Cortical Deficits in Schizophrenia: Have Genes, Will Hypothesize

Comment by:  Patricia Estani
Submitted 2 January 2006 Posted 2 January 2006
  I recommend the Primary Papers

Related News: SfN 2005: Nature or Nurture—Epigenetics in Neuronal Responses

Comment by:  Robert Fisher
Submitted 24 December 2005 Posted 3 January 2006

Dr. Eric Nestler at UT Southwestern Medical Center, Dallas, has long postulated addiction as a 50/50 percent split between genetic predisposition and biological changes as a result of substance abuse and the brain's accommodation to the same. I have found this particular hypothesis to be quite useful in treating addicts and alcoholics in inpatient and outpatient settings. They usually are able to easily grasp the concepts on a reasonably scientific level. This approach allows them to avoid guilt, shame, ect., that are typically strong predictors of success or failure in treatment. It is an even more successful tool in working with co-occurring Axis I disorders.

View all comments by Robert Fisher


Related News: Priming the LTP Pump—Dopamine Delivers in Prefrontal Cortex

Comment by:  Andreas Meyer-Lindenberg
Submitted 15 May 2006 Posted 15 May 2006
  I recommend the Primary Papers

I think this is an interesting paper, as it shows that alterations in tonic dopaminergic stimulation can result in a pronounced and qualitative switch (LTD to LTP) in the behavior of prefrontal neurons. Although the concept of tonic versus phasic dopaminergic stimulation has been adopted widely by the schizophrenia research community, the majority of the preclinical work has focused on acute changes in dopamine concentration and on subcortical structures, especially the nucleus accumbens, and from my perspective as a clinical researcher, it is welcome to see some data that extend to prefrontal cortex and longer timescales, although it must be emphasized that this paper concerns results from rats, in slices in vitro, using tetanic stimulation, and that the pretreatment with dopamine lasted for 40 minutes only. With these caveats, it is exciting to see that pretreatment with dopamine after what the authors presume is a 4-hour period of neurotransmitter depletion during slice preparation produces LTP after a weak tetanic stimulus, compared to LTD that the same stimulus evoked...  Read more


View all comments by Andreas Meyer-Lindenberg

Related News: Priming the LTP Pump—Dopamine Delivers in Prefrontal Cortex

Comment by:  Patricia Estani
Submitted 3 June 2006 Posted 3 June 2006
  I recommend the Primary Papers

Related News: Priming the LTP Pump—Dopamine Delivers in Prefrontal Cortex

Comment by:  Terry Goldberg
Submitted 20 June 2006 Posted 20 June 2006

Matsuda et al. demonstrate that priming D1 and D2 receptors may induce LTP; otherwise, LTD develops. To elaborate, a weak tetanic stimulation and dopamine stimulation produces LTD. However, if dopamine is perfused for 12 to 40 minutes at D1 and D2 receptors and a tetanic stimulus is provided, LTP, a form of cellular learning associated with memory, develops. This study has potentially important implications for understanding the cause of prefrontally based failures in information processing in schizophrenia. It gives additional weight to arguments that reduced dopaminergic tone at the cortical level is responsible for at least some of the cognitive problems associated with the disorder.

It also helps make sense out of some otherwise anomalous data in the literature. For instance, in manipulations of several tests of purported attentional control and vigilance problems, findings appeared more consistent with difficulties in constructing a representation than with attention per se in target detection (e.g.,   Read more


View all comments by Terry Goldberg

Related News: Priming the LTP Pump—Dopamine Delivers in Prefrontal Cortex

Comment by:  Satoru Otani
Submitted 22 July 2006 Posted 24 July 2006

In his June 20 comment, Dr. Goldberg raised an important question concerning our paper: how our results, showing the necessity of D1+D2 receptor coactivation for prefrontal LTP induction and priming, fit into the scheme proposed by Seamans et al., 2001, that is, the differential roles played by D1 and D2 receptors for prefrontal cortex (PFC) cognitive processes.

I think I have to first point out that the dependency of PFC long-term potentiation (LTP) induction (let alone "priming" now) on DA receptor subtypes may vary among subpopulations of PFC synapses. In ventral hippocampus (HC)-PFC synapses, LTP induction requires D1 but not D2 receptors (Gurden et al., 2000). This in vivo study fits with the idea that HC-PFC projection and its D1 receptor-mediated modulation are critical in spatial information processing (working memory) and encoding of this information. However, recent in vivo results of Yukiori Goto at the...  Read more


View all comments by Satoru Otani

Related News: Priming the LTP Pump—Dopamine Delivers in Prefrontal Cortex

Comment by:  Jeremy Seamans
Submitted 26 July 2006 Posted 27 July 2006

Drs. Goldberg and Otani raise some excellent points in their comments on the Matsuda et al. paper. As Dr. Otani alluded to in his latest comment, it is useful to define exactly what is being modulated under different experimental conditions and how this all relates to prefrontal cortex (PFC) function in general.

Dr Otani’s studies investigate synaptic plasticity induced by tetanic stimulation and how this process is modulated by tonic dopamine (DA). Long-term potentiation/long-term depression (LTP/LTD) induced by tetanic stimulation has provided us with perhaps the best model of the cellular basis of long-term memory and has been proposed to underlie, among other things, various aspects of long-term spatial memory and declarative memory. LTP is a long-lasting, passive, associational memory mechanism, unlike working memory that is transient in nature, relies on active processing and is not associational. Therefore, in PFC, it would be highly unlikely that LTP/LTD is the neural mechanism of working memory. However, to solve a working memory problem, one must manipulate...  Read more


View all comments by Jeremy Seamans

Related News: The New "Inverted U”—Cellular Basis for Dopamine Response Pinpointed

Comment by:  Andreas Meyer-Lindenberg
Submitted 8 February 2007 Posted 8 February 2007

This fascinating paper contributes to our mechanistic understanding of a fundamental nonlinearity governing the response of prefrontal neurons during working memory to dopaminergic stimulation: the “inverted U” response curve (Goldman-Rakic et al., 2000), which proposes that an optimum range of dopaminergic stimulation exists, and that either too little or too much dopamine impairs tuning, or the relationship between task-relevant (“signal”) and task-irrelevant (“noise”) firing of these neurons. On the level of behavior, this is predicted to result in impaired working memory performance outside the optimum middle range, and this has been confirmed in a variety of species. This is a topic of high relevance for schizophrenia where prefrontal dysfunction and related cognitive deficits, and dopaminergic dysregulation, have long been in the center of research interest (Weinberger et al., 2001), and may be linked (  Read more


View all comments by Andreas Meyer-Lindenberg

Related News: The New "Inverted U”—Cellular Basis for Dopamine Response Pinpointed

Comment by:  Terry Goldberg
Submitted 6 April 2007 Posted 6 April 2007

In this landmark study, Arnsten and colleagues used a full dopamine agonist in awake behaving monkeys to make key points about the inverted U response at the cellular level and how this maps to the behavioral level. There were a number of surprises. The first was that stimulation of the D1 receptor had consistently suppressive effects on neuronal firing during delays in a working memory task. The second was that when responses were optimized, suppressive effects differentially affected non-preferred directional neurons, rather than preferred direction neurons. Thus, it appeared that noise was reduced rather than signal amplified. Too much D1 stimulation resulted in suppression of both classes of neurons.

The implications of this work are important because it suggests that there is a neurobiological algorithm at work that can reliably produce this unexpected physiological pattern (perhaps as the authors suggest on the basis of baseline activity). It remains to be elucidated whether the D1 receptor effects are mediated by glutamatergic neurons or GABA interneurons, or both....  Read more


View all comments by Terry Goldberg

Related News: Biology of Reinforcement—Dopamine Linked to Three Separate Reward Paths

Comment by:  Patricia Estani
Submitted 16 November 2007 Posted 16 November 2007
  I recommend the Primary Papers

Related News: Epigenetic Analysis Finds Widespread DNA Methylation Changes in Psychosis

Comment by:  Dennis Grayson
Submitted 26 March 2008 Posted 27 March 2008
  I recommend the Primary Papers

The paper by Mill et al. is one of the first comprehensive attempts to examine changes in methylation across the entire genome in patients with various diagnoses of mental illness. The study is well designed, extensive, and uses fairly new technology to examine changes in methylation profiles across the genome. In the frontal cortex, the authors provide evidence for psychosis-associated differences in DNA methylation in numerous loci, including those involved in glutamatergic and GABAergic transmission, brain development, and other processes linked with disease etiology. Methylation in the frontal cortex of the BDNF gene is correlated with a non-synonymous SNP previously associated with major psychosis. These data provide further support for an epigenetic origin of major psychosis, as evidenced by DNA methylation-induced changes likely important to gene expression.

In many ways, this seems reminiscent of the trend in genetics several years ago when the inclination was to move from single gene loci association and linkage studies to genomewide scans. The only downside of...  Read more


View all comments by Dennis Grayson

Related News: Large Family Study Links Genetics of Schizophrenia, Bipolar Disorder

Comment by:  Alastair Cardno
Submitted 7 April 2009 Posted 7 April 2009
  I recommend the Primary Papers

The results of the family/adoption study by Lichtenstein et al. (2009) and our twin study (Cardno et al., 2002) are remarkably similar. Using a non-hierarchical diagnostic approach, the genetic correlation between schizophrenia and bipolar/mania was 0.60 in the family/twin study and 0.68 in the twin study. The heritability estimates were somewhat lower in the family/adoption (~60 percent) than twin study (~80 percent), but can still be said to be substantial and similar for both disorders.

When we adopted a hierarchical approach, with schizophrenia above mania, we found no monozygotic twin pairs where one twin had schizophrenia and the other had bipolar/mania, but with their considerably larger sample, Lichtenstein et al. (2009) were able to confirm a significantly elevated risk for bipolar disorder in siblings of probands with schizophrenia (RR = 2.7), even when individuals with co-occurrence of both disorders were excluded.

I think there is a potentially interesting link...  Read more


View all comments by Alastair Cardno

Related News: With Two Affected Parents, Schizophrenia Risk in Offspring Skyrockets

Comment by:  Peter Propping
Submitted 16 March 2010 Posted 16 March 2010

The study by Gottesman et al. is extremely important. Its value derives from the fact that the incidences come from a registry-based ascertainment of cases and from a country with national health insurance. Thus, the usual selective influences on ascertainment can largely be excluded. The empirical risk figures derived from this dual-mating study are much higher than in offspring where only one parent was affected by either schizophrenia or bipolar disorder. In the present study, however, the risk figures were somewhat lower than reported in some earlier studies (conducted in Germany, the United States, and the United Kingdom), where the cases had been ascertained through clinical admissions (Kahn, 1923; Kallman, 1938; Schulz, 1940; Elsässer, 1952; Lewis, 1957; Gershon et al., 1982). The major explanation is likely to be the ascertainment bias in the earlier studies.

Interestingly, this study found somewhat higher risks for both schizophrenia and bipolar disorder in the offspring...  Read more


View all comments by Peter Propping

Related News: With Two Affected Parents, Schizophrenia Risk in Offspring Skyrockets

Comment by:  Jehannine Austin
Submitted 19 March 2010 Posted 19 March 2010

The study recently published by Irving Gottesman and colleagues in the Archives has—as the authors point out—potentially important clinical implications. Using Denmark’s national registry data (>2.6 million individuals), the researchers calculated the cumulative incidences (to age 52) of psychiatric diagnoses in offspring of couples where one or both had previously been diagnosed with schizophrenia or bipolar disorder. The results clearly show that the probability of developing psychiatric illness is higher among offspring of individuals who have one parent with schizophrenia or bipolar disorder than among those who have no affected parents, and that the probability of developing psychiatric illness is highest among those who have both parents affected.

Probabilities that children will develop psychiatric disorders are of considerable interest amongst individuals with severe mental illnesses like schizophrenia and bipolar disorder. Further, American Psychiatric Association practice guidelines (American Psychiatric...  Read more


View all comments by Jehannine Austin
Submit a Comment on this News Article
Make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend the Primary Papers

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Share/Bookmark
Copyright © 2005- 2013 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright